Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 1.47b
Percent of AMI patients with left ventricular systolic dysfunction prescribed ACE inhibitor or angiotensin receptor blocker at discharge, all payers, by State, 2005
State Percent Standard error
United States 83.7 0.5
Alabama 82.9 0.8
Alaska 85.7 3.4
Arizona 83.3 0.9
Arkansas 80.5 1.1
California 84.0 0.4
Colorado 91.4 1.0
Connecticut 81.9 1.1
Delaware 88.8 1.7
District of Columbia 82.4 2.5
Florida 81.2 0.5
Georgia 81.0 0.8
Hawaii 79.5 1.9
Idaho 84.1 2.4
Illinois 82.5 0.6
Indiana 83.2 0.7
Iowa 89.5 0.9
Kansas 87.2 1.1
Kentucky 79.2 0.8
Louisiana 81.3 0.9
Maine 79.2 1.8
Maryland 80.7 1.0
Massachusetts 83.1 0.7
Michigan 87.0 0.5
Minnesota 88.4 0.8
Mississippi 82.7 1.1
Missouri 85.9 0.6
Montana 86.2 2.1
Nebraska 84.8 1.5
Nevada 84.1 1.7
New Hampshire 89.2 1.4
New Jersey 89.0 0.6
New Mexico 75.4 2.0
New York 83.6 0.4
North Carolina 85.3 0.6
North Dakota 88.5 1.9
Ohio 83.8 0.5
Oklahoma 86.3 1.0
Oregon 84.0 1.2
Pennsylvania 80.3 0.5
Puerto Rico 75.0 1.4
Rhode Island 86.7 1.7
South Carolina 86.5 0.9
South Dakota 87.4 2.1
Tennessee 81.5 0.7
Texas 82.0 0.5
Utah 82.9 2.2
Vermont 71.7 2.9
Virginia 82.8 0.8
Washington 86.0 0.9
West Virginia 86.3 1.0
Wisconsin 84.6 0.8
Wyoming 79.8 4.4

Key: AMI: acute myocardial infarction; ACE: angiotensin converting enzyme.

Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.

 

AHRQ Advancing Excellence in Health Care